Yazar "Demir, Hacer" için listeleme
-
A case of diffuse large B-cell lymphoma clinically and pathologically confused with breast cancer A case of lymphoma that is confused with breast cancer
Culha, Yasar; Baykara, Meltem; Unlu, Beyza; Demir, Hacer; Davarci, Sena Ece; Gocun, Feriha Pinar Uyar; Oge, Ceren Bilkan (Bayrakol Medical Publisher, 2023)Primary breast lymphoma is defined as only the presence of disease in the breast without in any other region of the body. Diffuse large B cell lymphoma (DLBCL) is most common among lymphoma types and accounts for approximately ... -
A Single-center Experience of Synchronous and Metachronous Hematologic and Oncologic Tumors
The incidence of cancer is increasing in the world. With the developments in cancer treatment, the life expectancy of patients is prolonged and the incidence of secondary malignancies is increasing. We retrospetively ... -
Clinical and prognostic effects of microvascular density and FOXP3 positive T cells in breast cancer
Culha, Yasar; Ozdemir, Cigdem; Davarci, Sena Ece; Unlu, Beyza; Olgun, A. K. Mehmet; Demir, Hacer; Baykara, Meltem (Nature Portfolio, 2024)There are conflicting data regarding the prognostic effect of microvascular density (MVD) in breast cancer and its molecular subtypes. It is thought that high levels of FOXP3 + T cells in breast cancer are associated with ... -
The Comparison of Central Venous Port Catheters in Gastrointestinal Cancer Treatment
Objective: Patients with solid cancers frequently suffer from thrombosis, which is associated with considerable cost, morbidity, and mortality. The infusional chemotherapy regimen, especially in gastrointestinal cancers, ... -
Comparison of clinicopathological and prognostic features of breast cancer patients younger than 40 years and older than 65 years
Culha, Yasar; Davarci, Sena Ece; Unlu, Beyza; Ozaskin, Duygu; Demir, Hacer; Baykara, Meltem (Springer, 2024)Purpose This study aims to compare the clinicopathological and prognostic features of women aged 40 years and younger and 65 years and older with breast cancer. Methods Between January 2011 and December 2021, 136 female ... -
Comparison of the efficacy of mFOLFOX-6 and mDCF regimens in the treatment of metastatic gastric cancer: a multicenter retrospective study
Karhan, Ogur; Ileri, Serdar; Urakci, Zuhat; Sezgin, Yasin; Yildirim, Umit; Unlu, Beyza; Demir, Hacer (Sage Publications Ltd, 2025)Background: Metastatic gastric cancer (GC) and gastroesophageal junction (GEJ) cancer are associated with a poor prognosis. Recent advancements in treatment have incorporated trastuzumab, anti-PD-1 agents, and anti-claudin ... -
Correction: Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy
Karaçin, Cengiz; Öküzoğlu, Berna; Demirci, Ayşe; Keskinkılıç, Merve; Köse Baytemür, Naziyet; Yılmaz, Funda; Selvi, Oğuzhan; Erdem, Dilek; Avşar, Esin; Paksoy, Nail; Demir, Necla; Sezgin Göksu, Sema; Türker, Sema; Bayram, Ertuğrul; Çelebi, Abdüssamet; Yılmaz, Hatice; Kuzu, Ömer Faruk; Kahraman, Seda; Gökmen, İvo; Sakin, Abdullah; Alkan, Ali; Nayır, Erdinç; Uğraklı, Muzafer; Acar, Ömer; Ertürk, İsmail; Demir, Hacer; Aslan, Ferit; Sönmez, Özlem; Korkmaz, Taner; Celayir, Özde Melisa; Karadağ, İbrahim; Kayıkçıoğlu, Erkan; Şakalar, Teoman; Öktem, İlker Nihat; Eren, Tülay; Erül, Enes; Eylemer Mocan, Eda; Kalkan, Ziya; Yıldırım, Nilgün; Ergün, Yakup; Akagündüz, Baran; Karakaya, Serdar; Kut, Engin; Teker, Fatih; Çakan Demirel, Burçin; Karaboyun, Kubilay; Almuradova, Elvina; Ünal, Olçun Ümit; Oyman, Abdülkerim; Işık, Deniz; Okutur, Kerem; Öztosun, Buğra; Belen Gülbağcı, Burcu; Kalender, Mehmet Emin; Şahin, Elif; Seyyar, Mustafa; Özdemir, Özlem; Selçukbiricik, Fatih; Kanıtez, Metin; Dede, İsa; Gümüş, Mahmut; Gökmen, Erhan; Yaren, Arzu; Menekşe, Serkan; Ebinç, Senar; Aksoy, Sercan; İnanç İmamoğlu, Gökşen; Altınnbaş, Mustafa; Çetin, Bülent; Oyan Uluç, Başak; Er, Özlem; Karadurmuş, Nuri; Erdoğan, Atike Pınar; Artaç, Mehmet; Tanrıverdi, Özgür; Çiçin, İrfan; Şendur, Mehmet Ali Nahit; Oktay, Esin; Bayoğlu, İbrahim Vedat; Paydaş, Semra; Aydıner, Adnan; Kıvrak Salim, Derya; Geredeli, Çağlayan; Yavuzşen, Tuğba; Doğan, Mutlu; Hacıbekiroğlu, İlhan (BioMed Central, 2023)Background There is no standard treatment recommended at category 1 level in international guidelines for subsequent therapy after cyclin-dependent kinase 4/6 inhibitor (CDK4/6) based therapy. We aimed to evaluate which ... -
Does Vitamin D Replacement Alter the Chemotherapy Outcome in Lung Cancer
Objectives: Lung cancer accounts for 20% of cancer-related deaths worldwide. Several studies have shown that Vitamin D levels at the time of diagnosis are prognostic in lung cancer. In this study, we evaluated the relationship ... -
The effect of high standard uptake value in lung cancer metastatic lesions on survival
Aydın, Suphi; Balcı, Aydın; Dumanlı, Ahmet; Acar, Leyla Nesrin; Ayşin, Murat; Gencer, Adem; Öz, Gürhan; Demir, Hacer; Davarcı, Sena Ece (University of Zagreb Medical School, 2023)Aim: To assess how metastatic lesions with a higher maximum standard uptake value than the primary tumor affect survival in patients with lung cancer. Methods: The study enrolled 590 stage-IV lung cancer patients treated ... -
The Effect of Serum Adiponectin and Cortisol Levels on Prognosis in the Patients with Sepsis and Septic Shock
Demir, Hacer; Baloş Törüner, Füsun; Bukan, Neslihan (Kare Publishing, 2021)Objectives: Severe sepsis and septic shock are among the most important causes of death in the intensive care units. Sepsis is a severe stress condition. Hypothalamic-pituitary-adrenal axis plays an important role in ... -
The Effect of The Body Composition to Prognosis in Young Breast Cancer Patients
Beypınar, İsmail; Kaya, Furkan; Demir, Hacer (Akdeniz Üniversitesi, 2021)Objective In cancer patients, the effect of the body composition on prognosis is a new clinical area of interest. In patients with class 2 or 3 obesity (BMI >35), survival was found to be worse control groups in a pooled ... -
The Effect of the Prognostic Nutritional Index on Chemoradiotherapy Response in Lung Cancer
Demir, Hacer; Beypınar, İsmail; Baykara, Meltem (2020)Objective: Lung cancer (LC) is the leading cause of death due to cancer worldwide. The non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC) comprise approximately 85% of the malignant lung tumors. The ... -
The effectiveness and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early-stage human epidermal growth factor receptor 2-positive breast cancer: Turkish Oncology Group study
Özdemir, Özlem; Zengel, Baha; Yıldız, Yaşar; Oyan Uluç, Başak; Çabuk, Devrim; Özden, Ercan; Kıvrak Salim, Derya; Paydaş, Semra; Demir, Atakan; Diker, Ömer; Pilancı, Kezban Nur; Uysal Sönmez, Özlem; Vatansever, Sezai; Doğan, İzzet; Gülmez, Ahmet; Çakar, Burcu; Gürsoy, Pınar; Yıldırım, Mahmut Emre; Ayhan, Murat; Karadurmuş, Nuri; Aykan, Musa Barış; Çevik, Gökçen Tuğba; Şakalar, Teoman; Hacıbekiroğlu, İlhan; Belen Gülbağcı, Burcu; Dinçer, Murat; Bayır Garbioğlu, Duygu; Kemal, Yasemin; Nayır, Erdinç; Taşkaynatan, Halil; Yılmaz, Mesut; Avcı, Okan; Sarı, Murat; Çoban, Ezgi; Atcı, Muhammed Mustafa; Aktürk Esen, Selin; Akın Telli, Tuğba; Karataş, Fatih; İnal, Ali; Demir, Hacer; Önal Kalkan, Nurhan; Yılmaz, Cengiz; Taşlı, Funda; Alacacıoğlu, Ahmet (Lippincott, Williams & Wilkins, 07.06.2022)In our study, we aimed to evaluate the pathological response rates and side effect profile of adding pertuzumab to the treatment of HER2+ locally advanced, inflammatory, or early-stage breast cancer. This study was conducted ... -
Efficacy of everolimus plus hormonal treatment after cyclin-dependent kinase inhibitor; real-life experience, A TOG study
Beypinar, Ismail; Demir, Hacer; Yaslikaya, Sendag; Koseci, Tolga; Demir, Bilgin; Colak, Gokhan; Agaoglu, Ahmet Burak (Springer, 2024)Purpose In advanced breast cancer, endocrine therapy is preferred in the absence of visceral crisis. Cyclin-dependent kinase inhibitors (CDKi) are the gold standards. The selection of subsequent treatments after CDKi ... -
Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy
Karaçin, Cengiz; Öksüzoğlu, Berna; Demirci, Ayşe; Keskinkılıç, Merve; Köse Baytemür, Naziyet; Yılmaz, Funda; Selvi, Oğuzhan; Erdem, Dilek; Avşar, Esin; Paksoy, Nail; Demir, Necla; Sezgin Göksu, Sema; Türker, Sema; Bayram, Ertuğrul; Çelebi, Abdüssamet; Yılmaz, Hatice; Kuzu, Ömer Faruk; Kahraman, Seda; Gökmen, İvo; Sakin, Abdullah; Alkan, Ali; Nayır, Erdinç; Uğraklı, Muzaffer; Acar, Ömer; Ertürk, İsmail; Demir, Hacer; Aslan, Ferit; Sönmez, Özlem; Korkmaz, Taner; Celayir, Özde Melisa; Karadağ, İbrahim; Kayıkçıoğlu, Erkan; Şakalar, Teoman; Öktem, İlker Nihat; Eren, Tülay; Erül, Enes; Eylemer Mocan, Eda; Kalkan, Ziya; Yıldırım, Nilgün; Ergün, Yakup; Akagündüz, Baran; Karakaya, Serdar; Kut, Engin; Teker, Fatih; Çakan Demirel, Burçin; Karaboyun, Kubilay; Almuradova, Elvina; Ünal, Olçun Ümit; Oyman, Abdülkerim; Işık, Deniz; Okutur, Kerem; Öztosun, Buğra; Belen Gülbağcı, Burcu; Kalender, Mehmet Emin; Şahin, Elif; Seyyar, Mustafa; Özdemir, Özlem; Selçukbiricik, Fatih; Kanıtez, Metin; Dede, İsa; Gümüş, Mahmut; Gökmen, Erhan; Yaren, Arzu; Menekşe, Serkan; Ebinç, Senar; Aksoy, Sercan; İnanç İmamoğlu, Gökşen; Altınbaş, Mustafa; Çetin, Bülent; Oyan Uluç, Başak; Er, Özlem; Karadurmuş, Nuri; Erdoğan, Atike Pınar; Artaç, Mehmet; Tanrıverdi, Özgür; Çiçin, İrfan; Şendur, Mehmet Ali Nahit; Oktay, Esin; Bayoğlu, İbrahim Vedat; Paydaş, Semra; Aydıner, Adnan; Kıvrak Salim, Derya; Geredeli, Çağlayan; Yavuzşen, Tuğba; Doğan, Mutlu; Hacıbekiroğlu, İlhan (BioMed Central, 2023)Background: There is no standard treatment recommended at category 1 level in international guidelines for subsequent therapy after cyclin-dependent kinase 4/6 inhibitor (CDK4/6) based therapy. We aimed to evaluate which ... -
Endometrium kanserli olgularda msı(mikrosatellit instabilite) sıklığı,klinikopatolojik özellikleri ve inflamasyon parametreleri ile ilişkisi
Küçük, Alptekin (Afyonkarahisar Sağlık Bilimleri Üniversitesi Akademik Arşiv Sistemi, 2020)Giriş ve Amaç: Endometrium kanseri gelişmiş ülkelerde en sık görülen jinekolojik malignitedir. Kolorektal kanserlerde MSI varlığının prognostik etkisi olduğunun keşfedilmesi jinekolojik malignitelerde de araştırılmasının ... -
Evaluating the effect of tumor size and sidedness on prognosis in stage 2 colon cancer: a retrospective population study
Demir, Hacer; Çağlayan, D; Kaman, O; İnanç, M; Urvay, Semiha; Beypınar, İsmail; Demirci, A; Davarcı, Sena Ece; Araz, M; Baykara, Meltem; Artaç, M; Yıldız, F (Verduci, 2022)OBJECTIVE: In this study, we aimed to evaluate the effect of tumor size and tumor sidedness on prognosis in patients with stage 2 colon cancer. PATIENTS AND METHODS: Data of 501 patients diagnosed with stage 2 colon cancer ... -
Here is the metastasis - find the primary carcinoma for it: a large biopsy study
Özdemir, Çiğdem; Şenol, Yiğit; Baykara, Meltem; Demir, Hacer; Sarıkaya, Yasin (Prusa Medikal Yayıncılık Limited Şirketi, 2023)Objectives: According to estimates, cancer of unknown primary origin (CUP) accounts for approximately 3 to 5% of new cancer cases annually in the United States. With early diagnosis, many CUP patients can achieve long-term ... -
Investigation of the Effect of Tumor Location in Patients with Stage III Colon Cancer Receiving Adjuvant Oxaliplatine-Based Adjuvant Chemotherapy
Urvay, Semiha; Demir, Hacer; Gökyer, Ali; Hacıbekiroğlu, İlhan; Küçükarda, Ahmet; Çakır, Emre; Beypınar, İsmail; Demir, Necla; Civelek, Burak; Özaslan, Ersin (Akad Doktorlar Yayinevi, 2021)Left-sided (LCC) and right-sided (RCC) colon cancers have different prognostic and predictive features in metastatic colon cancers, however there is insufficent data about tumor location in stage III disease. The aim of ... -
Is The COVID-19 Pandemic Reason, Shortage Result? A Survey Study on Drug Shortages in Turkish Oncology Clinics
Aim: The rapid development of the drug industry led to a great spectrum of medical treatment, especially in oncology practice. The prescribed drug alternations increased three times in the United States. Also, the increased ...
